Acro Biomedical Co., Ltd.
$0.03+0.00%(+$0.00)
TickerSpark Score
51/100
60
Valuation
40
Profitability
15
Growth
40
Health
100
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACBM research report →
52-Week Range25% of range
Low $0.00
Current $0.03
High $0.10
Companyacrobiomedicalco.com
Acro Biomedical Co. , Ltd. engages in developing and marketing of nutritional products.
- CEO
- Yu-Ting Su
- IPO
- 2021
- Employees
- 1
- HQ
- Fishers, IN, US
Price Chart
+2500.00% · this period
Valuation
- Market Cap
- $1.56M
- P/E
- -11.60
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -7.58
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 47.36%
- ROIC
- 48.07%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-101,146 · -139.13%
- EPS
- $-0.00 · -142.86%
- Op Income
- $-154,024
- FCF YoY
- -435.00%
Performance & Tape
- 52W High
- $0.10
- 52W Low
- $0.00
- 50D MA
- $0.03
- 200D MA
- $0.01
- Beta
- -2.54
- Avg Volume
- 59
Get TickerSpark's AI analysis on ACBM
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our ACBM Coverage
We haven't published any research on ACBM yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ACBM Report →Similar Companies
ONBI+0.00%
ONE Bio Corp.
$0.00
AMBS+0.00%
Amarantus BioScience Holdings, Inc.
$0.00
NSPDF+0.00%
Naturally Splendid Enterprises Ltd.
$0.04
MLPH+0.00%
Molecular Pharmacology (USA), Ltd.
$0.00
BSSP+0.00%
Baseline Productions, Inc.
$0.00
IBXG+0.00%
iBX Group, Inc.
$0.00
HDVY+0.00%
Health Discovery Corporation
$0.00
RGDXQ+0.00%
Response Genetics, Inc
$0.00